Michael Conklin bought $556K of Ryan Specialty (RYAN)
Executed Apr 1 2025, disclosed Apr 2 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Apr 2 2025), the stock returned -11.2% (delay-adjusted); from the execution session (Apr 1 2025), -11.4%. Derived: entry at the session's open, exit at the close 20 sessions later.
Michael Conklin (EVP & CHRO) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Ryan Specialty Holdings, Inc. (RYAN). Across 1 priced purchase filing, the average 21-session return was -11.4% from execution and -11.2% from disclosure (delay-adjusted; derived). The largest single filing was $556K of RYAN (as filed, as filed), executed Apr 1 2025.
Financial Services · Ryan Specialty Holdings, Inc. operates as a service provider of specialty products and solutions for insurance brokers, agents, and carrier…
More Financial Services filings→ Insider filings, newest first→ View the original filing at www.sec.gov→